World Health Organization/HIVResNet Drug Resistance Laboratory Strategy

S. Bertagnolio; I. Derdelinckx; M. Parker; J Fitzgibbon; H. Fleury; M. Peeters; R. Schuurman; D. Pillay; L. Morris; A. Tanuri; G.M. Gershy-Damet; J. Nkengasong; C.F. Gilks; D. Sutherland; P. Sandstrom

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy

Translated title of the contribution: World Health Organization/HIVResNet Drug Resistance Laboratory Strategy

S. Bertagnolio, I. Derdelinckx, M. Parker, J Fitzgibbon, H. Fleury, M. Peeters, R. Schuurman, D. Pillay, L. Morris, A. Tanuri, G.M. Gershy-Damet, J. Nkengasong, C.F. Gilks, D. Sutherland, P. Sandstrom

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	World Health Organization/HIVResNet Drug Resistance Laboratory Strategy
Original language	Undefined/Unknown
Pages (from-to)	49-57
Number of pages	9
Journal	Antiviral Therapy
Volume	13
Issue number	S2
Publication status	Published - 2008

Cite this

@article{ce123148c80c4706b042461c31cd036e,

title = "World Health Organization/HIVResNet Drug Resistance Laboratory Strategy",

author = "S. Bertagnolio and I. Derdelinckx and M. Parker and J Fitzgibbon and H. Fleury and M. Peeters and R. Schuurman and D. Pillay and L. Morris and A. Tanuri and G.M. Gershy-Damet and J. Nkengasong and C.F. Gilks and D. Sutherland and P. Sandstrom",

year = "2008",

language = "Undefined/Unknown",

volume = "13",

pages = "49--57",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "S2",

}

TY - JOUR

T1 - World Health Organization/HIVResNet Drug Resistance Laboratory Strategy

AU - Bertagnolio, S.

AU - Derdelinckx, I.

AU - Parker, M.

AU - Fitzgibbon, J

AU - Fleury, H.

AU - Peeters, M.

AU - Schuurman, R.

AU - Pillay, D.

AU - Morris, L.

AU - Tanuri, A.

AU - Gershy-Damet, G.M.

AU - Nkengasong, J.

AU - Gilks, C.F.

AU - Sutherland, D.

AU - Sandstrom, P.

PY - 2008

Y1 - 2008

M3 - Article

SN - 1359-6535

VL - 13

SP - 49

EP - 57

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - S2

ER -